💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for TRACON Pharmaceuticals, Inc. (TCON)
« Back to company indexTCON Chatter Timeline
Stock Ticker for TCON
Most Active Tweeters for TCON
| User | Tweets |
|---|---|
| @inoritrade | 10 |
| @Tickeron | 10 |
| @topologic_apple | 6 |
| @murphycpr | 6 |
| @Gambiste1 | 6 |
Recent Tweets for TCON
 |
@therockytrades $TCON tutes averaging down today. $144k buy December 3rd 2021, 10:12pm |
 |
@fintel_io Insider Opaleye Management Inc. reports buying 60,500 shares of $TCON for a total cost of $144,820.30 https://t.co/Fna1PulSoH #FNTL December 3rd 2021, 10:12pm |
 |
@bkfViking123 $tcon 's market cap is outrageous https://t.co/v5jvHn03jY December 3rd 2021, 6:12pm |
 |
@inoritrade $TCON Watching closely for a Spike with TCON https://t.co/nH42SG4DD5 December 3rd 2021, 3:12pm |
 |
@semodough February court hearing $IMAB vs $TCON definitely on my radar for 2022. https://t.co/ppz7kvCO2a December 3rd 2021, 1:12pm |
|
@bkfViking123 46.32% of the stock is owned by institutional investors. $tcon ... and dirt cheap December 3rd 2021, 1:12pm |
 |
@OptionHunt Ticker $TCON Unusual Volume Detected: 245.32% over average December 2nd 2021, 7:12pm |
|
@inoritrade $TCON Watching closely for a Spike with https://t.co/WBARPaK0Cc on TCON https://t.co/TdKDNw7diw December 2nd 2021, 4:12pm |
 |
@29Joujou $TCON dropped it, better fish to fry. still se a 4$ potential bounce, but I have better lines now https://t.co/8HQW8B0hWe December 2nd 2021, 3:12pm |
 |
@mopgcw trade not as quick as hoped. As i said, beware. added another slug of $tcon here @ $2.40. China approval positive, & more data shortly. December 2nd 2021, 3:12pm |
 |
@Gambiste1 RT @JacobPlieth: $TCON's SC anti-PD-L1 envafolimab got China approval this week; US ph3 study in biliary tract cancer ends Dec 2021 https:/… December 2nd 2021, 3:12pm |
|
@Gambiste1 RT @DipFinding: $TCON (HIGH Volume!) down 12.45% at $2.32 (Volume 7k, AvgVolume 249k) in the last 20 min December 2nd 2021, 3:12pm |
 |
@DipFinding $TCON (HIGH Volume!) down 12.45% at $2.32 (Volume 7k, AvgVolume 249k) in the last 20 min December 2nd 2021, 2:12pm |
 |
@shortablestocks $TCON is short sale restricted for 2021-12-02. https://t.co/uBMmXu4UUb December 2nd 2021, 2:12pm |
 |
@JacobPlieth $TCON's SC anti-PD-L1 envafolimab got China approval this week; US ph3 study in biliary tract cancer ends Dec 2021… https://t.co/ICJzNzkjpB December 2nd 2021, 11:12am |
 |
@Tickeron $TCON's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/j8rNWrNuft December 2nd 2021, 8:12am |
|
@Tickeron How does this affect your portfolio? $TCON RSI Indicator left the oversold zone. #TRACONPharmaceuticals… https://t.co/UGJ8xMrGHr December 2nd 2021, 6:12am |
|
@Tickeron This is why Hedge Funds use A.I. $TCON Aroon Indicator entered a Downtrend. #TRACONPharmaceuticals #stockmarket… https://t.co/GzG5irIn9k December 2nd 2021, 3:12am |
 |
@ShogunTrade $TCON Awaiting Buy Signal. Stock Trading Ideas by https://t.co/6vnULU2sSf https://t.co/3Zj9jRWYF0 December 1st 2021, 3:12pm |
|
@inoritrade $TCON Watching closely for a Spike with https://t.co/WBARPaK0Cc on TCON https://t.co/4dlHrDdgyt December 1st 2021, 1:12pm |
|
@therockytrades @pawcio2009 Now holding 100k+ $TCON my biopic 2021of the year. Probably need to rollover this pick into 2022. Is th… https://t.co/jUrlQRhhVG December 1st 2021, 12:12am |
 |
@IShopTheWorld RT @MichaelSDeVries: $TCON TRACON Pharmaceuticals Reports Regulatory Approval of Envafolimab in China| https://t.co/5yx4x5aKrc #TRACON #Ph… November 30th 2021, 8:11pm |
 |
@MichaelSDeVries $TCON TRACON Pharmaceuticals Reports Regulatory Approval of Envafolimab in China| https://t.co/5yx4x5aKrc #TRACON… https://t.co/KwGBGJwMu5 November 30th 2021, 8:11pm |
 |
@proactive_NA $TCON TRACON Pharmaceuticals partners receive approval of Envafolimab in China https://t.co/i54TjBYoI7 @TRACONPharma #TCON November 30th 2021, 8:11pm |
 |
@FreeWill1959 $TCON, $LPTX That is how they (MM) take money and shares from (but not from me) the individual investors. I don't u… https://t.co/3YUnJjQgFz November 30th 2021, 8:11pm |
|
@inoritrade $TCON Watching closely for a Spike with https://t.co/WBARPaK0Cc on TCON https://t.co/i2Nq26W35C November 30th 2021, 1:11pm |
 |
@ShortAlgoTrades $TCON Awaiting buy Signal. Stock Trading Ideas by https://t.co/jpmUt7BvVp #Investing #trading https://t.co/ry3ouiLimI November 30th 2021, 12:11pm |
 |
@1stOncology #TRACONPharmaceuticals Reports Regulatory Approval of #Envafolimab in China $TCON https://t.co/ywEc5Y5Tzx November 30th 2021, 7:11am |
 |
@boring_buffet RT @astockwatch1: TRACON Pharmaceuticals Reports Regulatory Approval of Envafolimab in China https://t.co/oAAe8BUhz0 $tcon #stocks #news #f… November 29th 2021, 9:11pm |
|
@astockwatch1 TRACON Pharmaceuticals Reports Regulatory Approval of Envafolimab in China https://t.co/oAAe8BUhz0 $tcon #stocks #news #fdaapproval #fda November 29th 2021, 7:11pm |
 |
@StckPro $TCON NEW ARTICLE : TRACON Pharmaceuticals notes partners' receipt of approval of Envafolimab in China… https://t.co/gCSZhPFQCy November 29th 2021, 4:11pm |
|
@StckPro $TCON NEW ARTICLE : TRACON Pharmaceuticals notes partners regulatory approval of Envafolimab in China… https://t.co/LLa6OuCgdN November 29th 2021, 4:11pm |
|
@inoritrade $TCON Waiting for Buy signal on TCON with https://t.co/WBARPaK0Cc https://t.co/mnWNVUNWPb November 29th 2021, 4:11pm |
|
@proactive_NA $TCON TRACON Pharmaceuticals wins regulatory approval of Envafolimab in China https://t.co/IYZBg4TqtK @TRACONPharma #TCON November 29th 2021, 3:11pm |
|
@Tickeron $TCON's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/OccvPXU7VP November 29th 2021, 3:11pm |
 |
@kchikian New position for me long $TCON insider buying and read out coming by end of year. November 29th 2021, 2:11pm |
|
@onerealridge @semodough @MBbiotech I guess somebody's gotta ask: Why with this drop after an approval? What's missing in the PR? $tcon November 29th 2021, 2:11pm |
 |
@TradeWithAlerts A nice print for $TCON at 9:30am -- SIDE: BelowBid Click https://t.co/dE4161UIVX for more. Runners ?:… https://t.co/NfzhcAlH5W November 29th 2021, 2:11pm |
 |
@realmaciej RT @semodough: @MBbiotech $TCON - would think $TCON very likely to hit on next readout November 29th 2021, 2:11pm |
|
@Gambiste1 RT @OryoJohn: $TCON: TRACON Pharmaceuticals Reports Regulatory Approval of Envafolimab in China $IKT: Inhibikase Therapeutics Announces P… November 29th 2021, 2:11pm |
 |
@topologic_apple @MattBiotech @MBbiotech $TCON was $12 before any data just few months ago. This data has a lot of bearing for final… https://t.co/MSXBNf5Yxg November 29th 2021, 2:11pm |
|
@FreeWill1959 $TCON Hmm, trading only around $3?! It's okay long term investors: short sellers can hold on their shorts only for… https://t.co/yqEYnEY7T2 November 29th 2021, 2:11pm |
|
@semodough @MBbiotech $TCON - would think $TCON very likely to hit on next readout https://t.co/f6vlXnK1dy November 29th 2021, 2:11pm |
|
@topologic_apple @MBbiotech $TCON has explosive potential over the next few weeks. Might get back to $10 region on good data. November 29th 2021, 2:11pm |
 |
@KaroshiTrading $TCON - News Quick Analysis: - Low float stock 19.18 Mio - GAP between 4.49 - 4.87$ - Daily low RSI @ 37.07 https://t.co/1vh0VFz8IV November 29th 2021, 1:11pm |
 |
@Longtermflow RT @semodough: $TCON First Approval of a Subcutaneously Administered Checkpoint Inhibitor in CHINA TRACON's Pivotal U.S. Trial for Envafol… November 29th 2021, 1:11pm |
 |
@mediasentiment $TCON new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 144 November 29th 2021, 1:11pm |
|
@mediasentiment $TCON new alert at https://t.co/A7qrDaJkzw #stocks #daytrading #NYSE #NASDAQ #market 144 November 29th 2021, 1:11pm |
 |
@OpenOutcrier $TCON (+11.5% pre) TRACON Pharmaceuticals Reports Regulatory Approval of Envafolimab in China - AP https://t.co/MRCIKimtEx November 29th 2021, 1:11pm |
|
@bkfViking123 $tcon call hit ... up 25% November 29th 2021, 1:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?